PD-033 Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy
Autor: | Ostrizkova, L., Petruželka, L., Hejduk, K., Zdražilová-Dubská, L., Vocka, M., Brancikova, D., Bencsiková, B., Vyzula, R., Obermannová, R. |
---|---|
Zdroj: | In Annals of Oncology June 2016 27 Supplement 2:ii114-ii114 |
Databáze: | ScienceDirect |
Externí odkaz: |